The present disclosure is directed to disposable absorbent articles and arrays of disposable absorbent articles which are designed to fit different adult body sizes, shapes and types, and as such are sized to fit a broad range of adult consumers.
The Waist Circumference and Side Length are illustrated in
The Waist Width and Side Length are illustrated in
As the Waist Circumference increases with BMI, Waist Circumference-to-Side Length Ratio and Body Waist-to-Side Silhouette both increase. A key benefit of having the Product Waist-to-Side Silhouette closer to that of the Body Waist-to-Side Silhouette and designed to change accordingly with BMI and Waist Circumference is that the product itself more closely matches the shape of the body. This results in the product being deformed to a significantly lesser degree during application than one that is generically designed to fit a bigger range as illustrated by the current marketed products. It also results in a product fit, which is more tailored to the body shape, providing more effective gasketing and better coverage and discretion. In fact, many of the current marketed products are designed to fit increments as large as 100 pounds and, as such do not provide adequate fit, gasketing, comfort and discretion across the entire range. Additionally, product designs which mimic the general shape of the body convey to consumers a better, more tailored fit as the Product Waist-to-Side Silhouettes are more similar to consumers' Body Waist-to-Side Silhouettes. The designs enabled by the present disclosure are more targeted by design, the product is located properly with respect to the waist and hip of the wearer and therefore provide a greater level of fit, gasketing, comfort and discretion.
Adult incontinence (“AI”) absorbent articles of the present disclosure may be used to absorb and contain liquid and other discharges from the human body to prevent the body and clothing from becoming soiled. For adults who suffer from urinary incontinence, urine voiding consists of two general types: stress urinary incontinence (“SUI”) and urge urinary incontinence (“UUI”). SUI is caused by high pressure on the bladder induced by coughing, sneezing, laughing, bending, etc., and can result in a high flow rate though at a smaller urine volume that is associated with UUI. UUI can result in a full bladder release, though at a lower flow rate than that associated with SUI.
Adult Incontinence articles come in a variety of designs, each typically available in multiple sizes, including 2, 3 and 4 size arrays. The size of articles of the prior art typically affects, for example, the size of the waist opening, the size of the openings around the thighs, and the length or “pitch” of the article. Many of these prior art articles are designed to fit ranges up to 100 pounds. The prior art articles are typically sized and sold by waist circumference dimension. The various sizes can have a range in waist circumference of as much as 12 inches and in some cases up to 16 inches. If a consumer selects an adult incontinence article of the prior art which is size appropriate based on the waist circumference dimension of the wearer given the large ranges associated with the various sizes, the thigh openings or pitch of the article, for instance, may be too large for proper fit on the wearer, potentially leading to slipping, sliding, sagging, drooping, or a loss of gasketing effects that are designed to inhibit leakage. Alternatively, depending on where the wearer is within the large size range, the thigh opening or pitch of the article may be too small for proper fit, potentially leading to wearer discomfort, skin marking of the wearer's skin or improper application or positioning of the article on the wearer.
Desirably, an adult absorbent article should be designed and sized to maintain contact with and conform as closely as possible to a wearer's body. Such a body-conforming design may increase the effectiveness of the adult absorbent article by reducing the possibility that urine, or the like, will spread or travel along the wearer's body and leak out of rather than be absorbed into the adult absorbent article. However, current adult absorbent articles on the market do not adequately address body shape or product shape and therefore do not fit a broad range of users adequately or provide the desired level of close fit. Typically AI packages of adult absorbent articles are labeled with a recommended wearer waist circumference range that the packaged article is intended to fit. As a result, the waist circumference is often the sole criteria used to identify the size of an AI article. The waist size does not in itself adequately describe the body shape of the individual and therefore does not help define the hip or thigh circumference nor the pitch that may be needed to provide the proper fit, comfort, coverage and gasketing of the article. This is the case even though other characteristics and anthropometric attributes of potential wearers (for example, age, height, weight, thigh circumference, and rise) may vary widely within the recommended waist circumference range, and may result in an ill-fitting article even though a wearer's waist circumference falls within that range. There is a need for adult absorbent articles that conform well to various wearers' body shapes and sizes. While there is a wide range of body shapes and sizes among women, available products do not reflect this wide range; rather, absorbent articles available today within a given product array tend to be scaled versions of each other, and do not even follow the natural trend of body shape and dimensional changes across the range of consumers, i.e. smaller to larger women as well as women of varying shape.
Body Mass Index (BMI) is on the rise globally for both men and women. In the U.S. alone, more than ⅓ of adult females are now considered obese (BMI>30). This has changed significantly over the past 30 years; in 1980 only about 16% of U.S. adult females were obese. Larger women exhibit different ratios of body anthropometrics than smaller women, i.e., all body dimensions do not simply scale-up as women get larger. In addition, women across the range of BMI may also have very different body shapes. There is a lack of recognition and understanding of this issue by current adult absorbent article manufacturers and as such consumers' needs are not being adequately met. Therefore, there is a need to develop adult absorbent articles for a wide variety of body shapes and sizes in order to provide an improved level of fit and contact between the body and the adult absorbent article to reduce the occurrence leakage and improve the overall fit, comfort, coverage and discretion of the article. There is a clear need for adult absorbent articles which are designed for variety of wearers based on their BMI and body shape. There is also a need to communicate to wearers the benefits of such customized adult absorbent articles in an easy-to-understand manner (e.g., some women may not understand what BMI is or know their BMI number), which is not off-putting (e.g., without stigmatizing or embarrassing women based on their BMI).
These are all objects of the present disclosure; embodiments of the present disclosure may combine various objects mentioned. A particular embodiment may, but need not, embody every object as described.
“Pull-on garment” or “pant” means articles of wear which have a defined waist opening and a pair of leg openings and which are pulled onto the body of the wearer by inserting the legs into the leg openings and pulling the article up over the waist.
“Disposable” means garments, which are not intended to be laundered or otherwise restored or reused as a garment (i.e., they are intended to be discarded after a single use and to be recycled, composted or otherwise disposed of in an environmentally compatible manner). The pull-on garment may be “absorbent” such that it absorbs and contains the various exudates discharged from the body.
“Closed form” means opposing waist regions are joined to form a continuous waist opening and leg openings. See
“Array” means a display of packages comprising disposable articles of different sizes having like article constructions (e.g., same elastomeric materials [compositionally and/or structurally] in the flaps, graphic elements) said packages having the same brand and/or sub-brand, and said packages oriented in proximity to each other in a given area of a retail store. An array is marketed as a line-up of products normally having like packaging elements (e.g., packaging material type, film, paper, dominant color, design theme, etc.) that convey to consumers that the different individual packages are part of a larger line-up. Arrays often have the same brand, for example, “Depend,” and same sub-brand, for example, “for Women Underwear.” A different array may have the brand “Depend” and the sub-brand “Silhouette For Women.” The differences between the “for Women Underwear” array and the “Silhouette For Women” arrays include different elastomeric materials in the side flaps, where “for Women Underwear” comprises strands as the elastomeric material and “Silhouette For Women” comprises a film elastomeric material.” Furthermore, the packaging is distinctly different in that “for Women Underwear” is packaged in a predominately green, film bag and “Silhouette For Women” is packaged in a predominately maroon box.
Further regarding “Arrays,” as another example of two separate “arrays” having the same brand, “Certainty,” one line-up has the sub-brand “Women's Underwear.” A different array may have the same brand “Certainty” and the sub-brand “Smooth Shape Briefs for Women.” The differences between the “Women's Underwear” array and the “Smooth Shape Briefs for Women” arrays include different elastomeric materials in the side flaps, where “Women's Underwear” comprises strands as the elastomeric material and “Smooth Shape Briefs for Women” comprises a film elastomeric material.” Furthermore, the packaging is distinctly different in that “Women's Underwear” is packaged in a predominately blue, film bag and “Smooth Shape Briefs for Women” is packaged in a predominately maroon box.
Arrays also often have the same trademarks, including trademarks of the brand, sub-brand, and/or features and/or benefits across the line-up.
“On-line Array” means an “Array” distributed by a common on-line source.
“Waist Circumference” means the horizontal circumference of the waist at the level of the center of the navel (omphalion). See
“Waist Width” is defined as the width of the body measured horizontally in the front of the body at the omphalion (center of navel). See
“Side Length” means the vertical distance from the navel to the level of the hip (where the hips are defined at the maximum prominent point of the buttocks as seen from the side. See
“Waist Circumference-to-Side Length Ratio” means the Waist Circumference (mm) divided by the Side Length (mm). See
“Body Waist-to-Side Silhouette” means the Waist Width (mm) divided by the Side Length (mm). See
“Product Waist-to-Side Silhouette” means Relaxed Product Waist Width (302) (mm) divided by the Relaxed Product Side Length (303) (mm). See
“Array Average Product Waist-to-Side Silhouette” means the average Product Waist-to-Side Silhouette of each size offered in a product array. For example, the Depend Underwear for Women (Maximum Absorbency) is marketed and sold in an array of 3 sizes: Small/Medium; Large and Extra Large. The Array Average Product Waist-to-Side Silhouette is the average of: The Product Waist-to-Side Silhouette for size Small/Medium; the Product Waist-to-Side Silhouette for size Large; and the Product Waist-to-Side Silhouette for size Extra Large. Table 1 shows examples of the Product Waist-to-Side Silhouette for some currently marketed product arrays.
“Relaxed Product Length” means the longitudinal distance between the longitudinally distal most point in the crotch region and the longitudinally distal most point along the front waist edge. The longitudinal distance is measured parallel to the longitudinal axis of the product. Refer to
“Relaxed Product Hip Width” means the lateral distance from the laterally distal most point of the left side edge of the product at the upper edge of the left leg opening to the laterally distal most point of the right side edge of the product at the upper edge of the right leg opening. Refer to
“Relaxed Product Waist Width” means the lateral distance from the distal most point at the right side of the front waist edge to the distal most point at the left side of the front waist edge. The lateral distance is measured perpendicular to the longitudinal axis of the product. Refer to
“Relaxed Product Side Length” means the linear distance from the point of intersection between the waist edge and the side edge of the product to the point of intersection between the top of the leg opening and the same side edge of the product. The relaxed product side length measurement is the average of the measurements from the left and right sides of the product. Refer to
“Target Waist Range” means the waist range as defined on each product package. For example, the Depend for Women Moderate Absorbency S/M package indicates a waist of 28-40 in (71-102 cm).
“Average Targeted Waist” means the average of the Target Waist Range. For example, the Depend for Women Moderate Absorbency S/M has a Target Waist Range (as defined on its package) of 71-102 cm. The Average Targeted Waist for this product is 86.5 cm.
Consumers who are urinary incontinent often are traumatized by the condition. Many aspects of the condition contribute to the trauma, like the fear of having an incontinent event in public. Even when wearing an absorbent article, there is still the fear of leaking, and the fear of her absorbent article being noticeable under her clothes. As such providing a product experience that helps normalize the condition by providing a more underwear-like, thin and body conforming structure across the entire BMI range is one of the objects of the present disclosure.
The body mass index (BMI) is a classification system for body shapes based upon height and mass. BMI may be calculated as follows:
The BMI comprises different classes of body mass, including: underweight (BMI<20), normal weight (BMI 20-25), overweight (BMI 25-30), obese (BMI 30-40), and morbidly obese (BMI>40).
One region where the shape of the female body changes as BMI gets higher is in the Body Waist-to-Side Silhouette. The Body Waist-to-Side Silhouette gets larger on average for larger women.
It may be desirable to link the Product Waist-to-Side Silhouette to that of the targeted consumers Body Waist-to-Side Silhouette in order to achieve a better fitting, better conforming, better gasketing product. This may increase the wearing comfort for each consumer while reducing leakage. Additionally, a product array where the Product Waist-to-Side Silhouette of each subsequently larger size follows the same general trend as the Body Waist-to-Side Silhouette for each subsequently larger size may also deliver a better fitting, better conforming article to each consumer regardless of their respective BMI.
While today's AI product arrays are not targeted toward the consumer's BMI, they are targeted toward their Waist Circumference. Table 1 details some of today's marketed product arrays (“comparative example arrays” or “existing product arrays”).
Table 2 below illustrates several inventive arrays of 2, 3, and 4 packages, whose Product Waist-to-Side Silhouettes match the trends of the consumers that they are targeted to fit and thereby provide better fit & comfort while reducing the chance of leakage. These inventive arrays are provided simply as non-limiting examples. Other inventive arrays are possible within the scope of this disclosure. These inventive arrays are also shown in
Absorbent Article
The absorbent articles of the present disclosure are generally designed and configured to manage bodily exudates such as urine, menses, feces or other vaginal discharges.
In one embodiment, an absorbent article may comprise a chassis comprising a topsheet, a backsheet, and an absorbent core disposed at least partially between the topsheet and the backsheet. The absorbent chassis may comprise a waistband, leg cuffs and or elastic strands. In various embodiments, referring to
In one embodiment, referring to
In one embodiment, referring to
In various embodiments, a portion of or the whole absorbent article 10 may be made to be laterally extensible. The extensibility of the absorbent article 10 may be desirable in order to allow the absorbent article 10 to conform to a body of a wearer during movement by the wearer. The extensibility may also be desirable, for example, in order to allow the caregiver to extend the front waist region 36, the back waist region 38, the crotch region 37, and/or the chassis 100 to provide additional body coverage for wearers of differing size, i.e., to tailor the absorbent article 10 to the individual wearer. Such extension may provide the absorbent article 10 with a generally hourglass shape, so long as the crotch region 37 is extended to a relatively lesser degree than the waist regions 36 and/or 38. This extension may also impart a tailored appearance to the absorbent article 10 during use.
Any or all portions of the absorbent article may comprise a bacteriophage composition as described in U.S. Ser. No. 61/931,229, titled DISPOSABLE ABSORBENT ARTICLES COMPRISING BACTERIOPHAGES AND RELATED METHODS, and filed on Jan. 24, 2014.
Topsheet
In one embodiment, referring to
Apertured film or nonwoven topsheets typically may be pervious to bodily exudates, yet non-absorbent, and have a reduced tendency to allow fluids to pass back through and rewet the wearer's skin. Suitable woven and nonwoven materials may comprise natural fibers, such as, for example, wood or cotton fibers, synthetic fibers, such as, for example, polyester, polypropylene, or polyethylene fibers, or combinations thereof. If the topsheet 81 comprises fibers, the fibers may be spunbond, carded, wet-laid, meltblown, hydroentangled, or otherwise processed, for example, as is generally known in the art.
The topsheet may comprise a skin care lotion. Examples of suitable lotions include, but are not limited to, those described in U.S. Pat. Nos. 5,607,760; 5,609,587; 5,635,191; 5,643,588; and 5,968,025, and as described in U.S. Application No. 61/391,353.
In one embodiment, the topsheet may comprise graphics (e.g., 116 in
Backsheet
In one embodiment, referring to
One suitable material for the backsheet can be a liquid impervious thermoplastic film having a thickness of from about 0.012 mm (0.50 mil) to about 0.051 mm (2.0 mils), for example including polyethylene or polypropylene. Typically, the backsheet can have a basis weight of from about 5 g/m2 to about 35 g/m2. The backsheet can be typically positioned adjacent the outer-facing surface of the absorbent core and can be joined thereto. For example, the backsheet may be secured to the absorbent core by a uniform continuous layer of adhesive, a patterned layer of adhesive, or an array of separate lines, spirals, or spots of adhesive. Illustrative, but non-limiting adhesives, include adhesives manufactured by H. B. Fuller Company of St. Paul, Minn., U.S.A., and marketed as HL-1358J. An example of a suitable attachment device including an open pattern network of filaments of adhesive is disclosed in U.S. Pat. No. 4,573,986. Another suitable attachment device including several lines of adhesive filaments swirled into a spiral pattern is illustrated by the apparatus and methods shown in U.S. Pat. Nos. 3,911,173; 4,785,996; and 4,842,666. Alternatively, the attachment device may include heat bonds, pressure bonds, ultrasonic bonds, dynamic mechanical bonds, or any other suitable attachment device or combinations of these attachment devices.
In one embodiment, the backsheet 83 may be embossed and/or matte-finished to provide a more cloth-like appearance. Further, the backsheet 83 may permit vapors to escape from the absorbent core of the absorbent article 10 (i.e., the backsheet 83 is breathable) while still preventing, or at least inhibiting, fluids or body exudates from passing through the backsheet 83. In one embodiment, the size of the backsheet 83 may be dictated by the size of the absorbent article 10 and the design or configuration of the absorbent article 10 to be formed, for example.
Absorbent Core
In various embodiments, referring to
In one embodiment, suitable absorbent cores may comprise cellulosic airfelt material. For instance, such absorbent cores may comprise less than about 40%, 30%, 20%, 10%, 5%, or even 1% of the cellulosic airfelt material as determined by weight. Additionally, such an absorbent core may be primarily comprised of an absorbent gelling material in amounts of at least about 60%, 70%, 80%, 85%, 90%, 95%, or even about 100% as determined by weight. Furthermore, a portion of the absorbent core may comprise a microfiber glue (if applicable). Such absorbent cores, microfiber glues, and absorbent gelling materials are described in U.S. Pat. Nos. 5,599,335; 5,562,646; 5,669,894; 6,790,798; and 7,521,587 and in U.S. Pat. Publ. No. 2004/0158212.
In one embodiment, the core, including multiple layers making up the core system, may be printed and embossed as described in U.S. Pat. No. 8,536,401.
In one embodiment, the core may be separable from the chassis as disclosed in U.S. Pat. Nos. 6,989,006; 7,381,202; 7,175,613; 7,824,386; 7,766,887; and 6,989,005. In such embodiments, the measurements described in this disclosure may be made to the chassis alone or may be made to the chassis in combination with the separable core/absorbent assembly.
In one embodiment, the absorbent article of the present disclosure, and particularly, a portion where the absorbent member is disposed, may have a body fluid absorption rate greater than 3 g/sec according to U.S. Pat. No. 6,649,810. According to U.S. Pat. No. 6,649,810, the expression “the portion (of the absorbent article) where the absorbent member is disposed” is intended to mean the portion occupied by the absorbent member when the absorbent article is flatly unfolded and seen in its plan view.
In one embodiment, the absorbent structure may have an intake factor greater than 3 according to U.S. Pat. No. 7,073,373, wherein the intake factor is defined as the absorbent core permeability divided by the normalized retention capacity (which is defined by the Retention Capacity Test—also according to U.S. Pat. No. 7,073,373).
In one embodiment, the absorbent composite has a body fluid absorption greater than 75 g/100 cm2, according to U.S. Pat. No. 6,649,810.
In one embodiment, a target location of the absorbent article may have a wicking value greater than 36%, according to U.S. Pat. No. 6,383,960.
In one embodiment, the absorbent article may have a bending stiffness between 0.05-1.0 gf, according to U.S. Pat. No. 5,810,796.
In one embodiment, the absorbent article may have a crotch fluid absorption rate greater than 3 g/sec according to U.S. Pat. No. 6,649,810. In one embodiment, a freeze-dried composite of the absorbent composite may have an intake rate of at least about 1.9 cubic centimeters (cc) of liquid/second at 80% composite saturation according to U.S. Pat. No. 6,689,934.
Leg Cuffs
In one embodiment, referring to
In one embodiment, each leg cuff 147 may comprise a proximal edge 157a and 157b. These edges 157a and 157b are positioned proximate to the longitudinal axis 42 compared to distal edges 139a and 139b. The leg cuffs 147 may overlap the absorbent core 200, i.e., the proximal edges 157a and 157b lie laterally inward of the respective side edges 237a and 237b of the absorbent core 200. Such an overlapped configuration may be desirable in order to impart a more finished appearance to the absorbent article 10 than that imparted by a non-overlapped configuration. In other embodiments, the leg cuffs 147 may not overlap the absorbent core 200.
In one embodiment, each leg cuff 147 may be attached to the interior surface 102 of the chassis 100 in a leg cuff attachment zone (not shown) adjacent to the front waist end edge 136 and in a longitudinally opposing leg cuff attachment zone (not shown) adjacent to the back waist end edge 138. In one embodiment, between the leg cuff attachment zones, the proximal edge 157 of the leg cuff 147 remains free, i.e., not attached to the interior surface 102 of the chassis 100 or to the absorbent core 200. Also, between the longitudinally opposing leg cuff attachment zones, each leg cuff 147 may comprise one or more (specifically including one, two, three, or four elastic strands per leg cuff 147) longitudinally extensible cuff elastic gathering members 159 that may be disposed at or adjacent to the proximal edge 157 of the leg cuff 147 by any suitable methods. Each of such cuff elastic gathering members 159 may be attached over the leg cuff's entire length or over only a portion of the leg cuff's length. For example, such cuff elastic gathering members 159 may be attached only at or near the leg cuff's longitudinally opposing ends and may be unattached at the middle of the leg cuff's length. Such cuff elastic gathering members 159 may be disposed in the crotch region 37 and may extend into one or both of the front waist region 36 and the back waist region 38. For example, an elastic gathering member 159 may be attached at or adjacent to the proximal edge 157 of each of the leg cuffs 147 and extends into both the front waist region 36 and the back waist region 38.
In various embodiments, each cuff elastic gathering member 159 may be enclosed inside a folded hem for example. In various embodiments, the cuff elastic gathering members 159 may be sandwiched between two layers forming the leg cuff 147, by two layers of the chassis 100, or may be attached on a surface of the chassis 100 or the leg cuff 147 and remain exposed.
In one embodiment, when stretched, the cuff elastic gathering member 159 disposed adjacent to each leg cuff's proximal edge 157 allows the leg cuff proximal edge 157 to extend to the flat uncontracted length of the chassis 100, e.g., the length of the chassis 100. When allowed to relax, the cuff elastic gathering member 159 contracts to pull the front waist region 36 and the back waist region 38 toward each other and, thereby, bend the article 10 into a “U” shape in which the interior of the “U” shape may be formed by the portions of the article 10 that are intended to be placed toward the body of the wearer (i.e., interior surface 102). Because each of the proximal edges 157 remains free between the longitudinally oriented leg cuff attachment zones, the contractive force of the elastic gathering member 159 may lift the proximal edge 157 of the leg cuff 147 away from the interior surface 102 of the chassis 100. This lifting of the proximal edges 157 when the article 10 is in the relaxed condition lifts the leg cuffs 147 into a position to serve as side barriers to prevent, or at least inhibit, leakage of bodily exudates.
Waistband
In one embodiment, referring to
In one embodiment, the elasticized waistbands may comprise materials that have been “prestrained” or “mechanically prestrained” (i.e., subjected to some degree of localized pattern mechanical stretching to permanently elongate the material). The materials may be prestrained using suitable deep embossing techniques. In other embodiments, the materials may be prestrained by directing the material through an incremental mechanical stretching system as described in U.S. Pat. No. 5,330,458. The materials may then be allowed to return to their substantially untensioned condition, thus forming a zero strain stretch material that is extensible, at least up to the point of initial stretching. Examples of zero strain materials are disclosed in U.S. Pat. Nos. 2,075,189, 3,025,199, 4,107,364, 4,209,563, 4,834,741, and 5,151,092.
Flaps
The flaps 189 (a-d) may be discrete from or integral with the chassis 100. A discrete flap is formed as separate element, which is joined to the chassis 100. In some embodiments, this includes a plurality of flaps, e.g. 2 or 4 (often referred to as ear panels or side flaps) being joined to the side edges 137a and b of the chassis in the front and/or rear waist regions 36 and 38 (see
The belt-like flaps and may comprise an inner nonwoven layer and an outer nonwoven layer and elastics there between. The inner and outer nonwoven layers may be joined using adhesive or thermoplastic bonds. Various suitable belt-like flap configurations can be found in U.S. Pub. No. 2013-0211363.
An integral flap is a portion, one or more layers, of the chassis that projects laterally outward from the longitudinal edge. The integral flap may be formed by cutting the chassis to include the shape of the flap projection.
While many of the embodiments illustrated in this application having belt-like flaps are pant articles, taped articles may have belt-like flaps disposed in one or both waist regions as well.
The structure of flaps play an important role in the functionality of the absorbent article and are fundamentally different than the elastics used in underwear. As mentioned above, incontinence events, such as SUI and UUI, can result in a high flow rate and/or a full bladder release. The amounts of urine expelled during the incontinence events can vary wildly given the type of urinary incontinence as well as other circumstances such as time since last bathroom visit, amount of fluid intake, day or night, etc. Loadings can range from as low as a few drops of urine to loadings as high as 600 mls. It is not unusual to have single loadings as high as 300, 400 and even 500 mls. These levels of loading present a significant downward force associated with the loading which can be a pound or more. This downward force must be compensated for by the absorbent article chassis in order to minimize sagging, gapping and leakage. In order to sustain the fit of the article even after loading the article comprises elastomeric element(s) 146, including films and/or strands) that are disposed proximate to and along the side seams 280a and b (see, for example,
Fastening System
The absorbent article may also include a fastening system. When fastened, the fastening system interconnects the front waist region 36 and the rear waist region 38 resulting in a waist circumference that may encircle the wearer during wear of the absorbent article 10. This may be accomplished by flaps 189a and b in the back waist region interconnecting with flaps 189c and d in the front waist region or by flaps in the back waist region interconnecting with the chassis 100 in the front waist region. The fastening system may comprises a fastener 53a and b such as tape tabs, hook and loop fastening components, interlocking fasteners such as tabs & slots, buckles, buttons, snaps, and/or hermaphroditic fastening components, although any other known fastening means are generally acceptable. The fasteners may releasably engage with a landing zone 118, which may be a woven or nonwoven. Some exemplary surface fastening systems are disclosed in U.S. Pat. Nos. 3,848,594; 4,662,875; 4,846,815; 4,894,060; 4,946,527; 5,151,092; and 5,221,274. An exemplary interlocking fastening system is disclosed in U.S. Pat. No. 6,432,098. The fastening system may also provide a means for holding the article in a disposal configuration as disclosed in U.S. Pat. No. 4,963,140. The fastening system may also include primary and secondary fastening systems, as disclosed in U.S. Pat. No. 4,699,622. The fastening system may be constructed to reduce shifting of overlapped portions or to improve fit as disclosed in U.S. Pat. Nos. 5,242,436; 5,499,978; 5,507,736; and 5,591,152.
Identical or Substantially Identical Chassis
As disclosed in U.S. Pub. No. 2013-0211355, it may be desirable to offer an array of packages for fitting different sized wearers, but comprising identical or substantially identical chassis. For instance, an array may comprise a first package comprising a first size of absorbent articles and a second package may comprise a second size of absorbent articles, where the first and second packages comprise identical or substantially identical chassis as described in U.S. Pub. No. 2013-0211355. More particularly, the first package may comprise a first chassis and the second package may comprise a second chassis, where each of the first and second chassis comprise the same dimensions of one or more of: core width at the lateral centerline, core width at one of the front or rear core end, a distance from a left outer cuff distal edge to a right outer cuff distal edge, a distance from a left inner cuff distal edge to a left outer cuff distal edge, a distance from a left inner cuff proximal edge to a right inner cuff proximal edge, a distance from a left inner cuff proximal edge to a left outer cuff distal edge, a free height of the inner cuff, inner cuff hem fold width, inner cuff elastics length, outer cuff elastics length, core length, and backsheet width.
Further, each of the first and second chassis may comprise identical chemical compositions of one or more of a topsheet, backsheet film, backsheet nonwoven, core super absorbent polymers, core pulp, core nonwoven, core tissue, leg cuff film, leg cuff nonwoven, super absorbent polymer adhesive, core nonwoven adhesive, leg cuff elastic adhesive, and backsheet nonwoven/film adhesive.
And, each of the first and second chassis may comprise the same basis weight of one or more of the topsheet, backsheet film, backsheet nonwoven, core super absorbent polymers, core pulp, leg cuff nonwoven, leg cuff film, super absorbent polymer adhesive, leg cuff adhesive, and backsheet nonwoven/film adhesive.
And, each of the first and second chassis may comprise compositionally identical core super absorbent polymers. The first and second chassis may have identical component cross sectional order and disposition in at least one of the front waist region, back waist region, and crotch region. The inner leg cuffs of the first and second chassis may be composed of the compositionally identical materials.
And, the core adhesives of the first and second chassis may be the same adhesive(s). The first and second chassis may comprise core super absorbent polymers that are in the same chemical class and subclass.
And, each of the first and second chassis may comprise first and second wetness indicators, respectively, and wherein the first and second wetness indicators are compositionally identical.
Further, the inner leg cuffs of the first and second chassis may have identical component cross sectional order and disposition in at least one of the front waist region, back waist region, and crotch region. The distance from the left outer cuff distal edge to a right outer cuff distal edge may the same. The distance from the left inner cuff proximal edge to left outer cuff distal edge may be the same. The distance from the left inner cuff proximal edge to the right inner cuff proximal edge is the same. The lengths of the inner and outer cuffs are the same.
In some embodiments, different size offerings in an array may have identical or substantially identical chassis as the flaps or belts may be used to enable the absorbent article to fit different sized wearers. For example, first and second absorbent articles may have identical chassis (compositionally, dimensionally, cross-sectionally), but the first article may have a different length due to disposition of the belts, such that the first article may be targeted to fit a smaller wearer than the second article. As a second example, first and second absorbent articles may have identical chassis (compositionally, dimensionally, cross-sectionally), but the first article may have a different length and/or width due to the size of the belts, such that the first article may be targeted to fit a smaller wearer than the second article.
In some embodiments, first and second absorbent articles may have identical chassis compositionally, but not dimensionally, and not cross-sectionally. In some embodiments, first and second absorbent articles may have identical chassis dimensionally, but not compositionally, and not cross-sectionally. In some embodiments, first and second absorbent articles may have identical chassis cross-sectionally, but not dimensionally, and not compositionally. In still other embodiments, first and second absorbent articles may have two, but not three of (1) compositionally, (2) dimensionally, and (3) cross-sectionally identical chassis.
Test Methods
Product Measurement Preparation
All measurements are conducted at 22° C.+/−2° and 50% RH+/−20%.
Purpose
This method is used to prepare pant type products for subsequent dimensional measurement. The method provides a consistent means of opening a product that has been removed from a bag. This method is applicable to all forms of pant products. A constant rate of extension tensile testing machine with computer interface is used.
A load cell is chosen so that the load cell capacity ensures accuracy of a 5N load to within 0.1N.
Sample Holder Apparatus
“C” (304) and “O” (305) Bar attachments each with a rod radius of 9.50 mm that extend longer than the length of the longest side seam. Refer to
Equipment Set Up
Calibrate tensile tester equipment according to the instrument manufacturer's recommendations.
The initial gauge length is determined by removing 10 sample products from the bag, unfolding the pant products (307) and laying them flat as illustrated in
Apply the whole product (307) to the bars as shown in
Pull Sample to 5N Force then hold for 10 seconds. Return to initial gauge length.
Crosshead Speed=254.0 mm/min, Data acquisition rate=50 Hz.
Cycles=1
Remove the specimen from the bars while minimizing manipulation. Lay the specimen flat with the front side facing upward as shown in
Repeat for all 10 specimens
Physical Measurements
Each of the measurements below is to be conducted on 10 separate like specimens and the average of the 10 separate like specimens is considered to be the measurement for that specific specimen set.
Relaxed Product Length (300)
Relaxed Product Length is the longitudinal distance between the longitudinally distal most point in the crotch region and the longitudinally distal most point along the front waist edge. The longitudinal distance is measured parallel to the longitudinal axis of the product. Refer to
Relaxed Product Hip Width (301)
Relaxed Product Hip Width is the lateral distance from the laterally distal most point of the left side edge of the product at the upper edge of the left leg opening to the laterally distal most point of the right side edge of the product at the upper edge of the right leg opening. Refer to
Relaxed Product Waist Width (302)
Relaxed Product Waist Width is the lateral distance from the distal most point at the right side of the front waist edge to the distal most point at the left side of the front waist edge. The lateral distance is measured perpendicular to the longitudinal axis of the product. Refer to
Relaxed Product Side Length (303)
Relaxed Product Side Length is the linear distance from the point of intersection between the waist edge and the side edge of the product to the point of intersection between the top of the leg opening and the same side edge of the product. The relaxed product side length measurement is the average of the measurements from the left and right sides of the product. Refer to
Each of the measurements above is recorded to within +/−1.0 mm
This application is a continuation of, and claims priority under 35 U.S.C. § 120 to, U.S. patent application Ser. No. 14/805,673, filed on Jul. 22, 2015 and U.S. patent application Ser. No. 14/699,123, filed on Apr. 29, 2015, which claims the benefit, under 35 USC § 119(e), of U.S. Provisional Patent Application Ser. No. 61/990,358 filed on May 8, 2014, the entire disclosures of which are fully incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
414637 | Goodson | Nov 1889 | A |
416794 | Mathieu | Dec 1889 | A |
421901 | Breher | Feb 1890 | A |
421902 | Britz | Feb 1890 | A |
437686 | Geddes | Oct 1890 | A |
443451 | Hunter | Dec 1890 | A |
443508 | Emmet | Dec 1890 | A |
445329 | Kerr | Jan 1891 | A |
451279 | Sailor | Apr 1891 | A |
3815602 | Johns et al. | Jun 1974 | A |
3967756 | Barish | Jul 1976 | A |
3982659 | Ross | Sep 1976 | A |
3994417 | Boedecker | Nov 1976 | A |
4117187 | Adams et al. | Sep 1978 | A |
4230113 | Mehta | Oct 1980 | A |
4299223 | Cronkrite | Nov 1981 | A |
4471881 | Foster | Sep 1984 | A |
4706845 | Schnurer et al. | Nov 1987 | A |
4743241 | Igaue et al. | May 1988 | A |
4840270 | Caputo et al. | Jun 1989 | A |
4885155 | Parran, Jr. et al. | Dec 1989 | A |
4940464 | Van Gompel et al. | Jul 1990 | A |
4966286 | Muckenfuhs | Oct 1990 | A |
4971220 | Kaufman et al. | Nov 1990 | A |
5004597 | Majeti | Apr 1991 | A |
5050737 | Joslyn et al. | Sep 1991 | A |
5065868 | Cornelissen et al. | Nov 1991 | A |
5151092 | Buell | Sep 1992 | A |
5231266 | Warren | Jul 1993 | A |
5242057 | Cook et al. | Sep 1993 | A |
5261901 | Guay | Nov 1993 | A |
5284263 | Papciak | Feb 1994 | A |
5322178 | Foos | Jun 1994 | A |
5366104 | Armstrong | Nov 1994 | A |
5368188 | Twardowski | Nov 1994 | A |
5377853 | Papciak | Jan 1995 | A |
5395358 | Lu | Mar 1995 | A |
5413849 | Austin et al. | May 1995 | A |
5443161 | Jonese | Aug 1995 | A |
5485919 | Samberg et al. | Jan 1996 | A |
5569234 | Buell et al. | Oct 1996 | A |
5575783 | Clear et al. | Nov 1996 | A |
5591155 | Nishikawa et al. | Jan 1997 | A |
5599620 | Huskey | Feb 1997 | A |
5647506 | Julius | Jul 1997 | A |
5678727 | Rice | Oct 1997 | A |
5685874 | Buell et al. | Nov 1997 | A |
5690627 | Clear et al. | Nov 1997 | A |
5695745 | Barton et al. | Dec 1997 | A |
5715841 | Utecht | Feb 1998 | A |
5732716 | Utecht | Mar 1998 | A |
5733530 | Bacca et al. | Mar 1998 | A |
5735839 | Kawaguchi et al. | Apr 1998 | A |
5746730 | Suzuki et al. | May 1998 | A |
5785179 | Buczwinski et al. | Jul 1998 | A |
5791465 | Niki et al. | Aug 1998 | A |
5817087 | Takabayashi et al. | Oct 1998 | A |
5839585 | Miller | Nov 1998 | A |
5865322 | Miller | Feb 1999 | A |
5885264 | Matsushita | Mar 1999 | A |
5938648 | LaVon et al. | Aug 1999 | A |
5944237 | Gouldson | Aug 1999 | A |
5947302 | Miller | Sep 1999 | A |
6013590 | Noda | Jan 2000 | A |
6024094 | Utecht | Feb 2000 | A |
6050985 | LaVon et al. | Apr 2000 | A |
6075178 | Wilhelm et al. | Jun 2000 | A |
6092690 | Bitowft et al. | Jul 2000 | A |
6168022 | Ward et al. | Jan 2001 | B1 |
6190369 | Palumbo et al. | Feb 2001 | B1 |
6195800 | Gilmer et al. | Mar 2001 | B1 |
6229061 | Dragoo et al. | May 2001 | B1 |
6258077 | Buell et al. | Jul 2001 | B1 |
6269969 | Huang et al. | Aug 2001 | B1 |
6269970 | Huang et al. | Aug 2001 | B1 |
6274218 | Shingo | Aug 2001 | B1 |
6296144 | Tanaka et al. | Oct 2001 | B1 |
6302871 | Nakao et al. | Oct 2001 | B1 |
6315114 | Keck et al. | Nov 2001 | B1 |
6361784 | Brennan et al. | Mar 2002 | B1 |
6401968 | Huang et al. | Jun 2002 | B1 |
6412634 | Telesca et al. | Jul 2002 | B1 |
6454095 | Brisebois et al. | Sep 2002 | B1 |
6488202 | Seitz et al. | Dec 2002 | B1 |
6491165 | Kuske et al. | Dec 2002 | B2 |
6500444 | Ferenc et al. | Dec 2002 | B1 |
6520946 | Krueger | Feb 2003 | B1 |
6568530 | Takahashi et al. | May 2003 | B2 |
6581775 | Hagopian | Jun 2003 | B1 |
6601705 | Molina et al. | Aug 2003 | B2 |
6612846 | Underhill et al. | Sep 2003 | B1 |
6648864 | Ronn et al. | Nov 2003 | B2 |
6649808 | Tao | Nov 2003 | B1 |
6667464 | Ellis | Dec 2003 | B2 |
6763944 | Ronn et al. | Jul 2004 | B2 |
6830755 | Librizzi et al. | Dec 2004 | B2 |
6837395 | Windorski et al. | Jan 2005 | B2 |
6911022 | Steger et al. | Jun 2005 | B2 |
7008685 | Groitzsch et al. | Mar 2006 | B2 |
7118558 | Wu | Oct 2006 | B2 |
7222732 | Ronn et al. | May 2007 | B2 |
7549538 | Naoe et al. | Jun 2009 | B2 |
7572249 | Betts | Aug 2009 | B2 |
7582075 | Betts et al. | Sep 2009 | B2 |
7770729 | Warren et al. | Aug 2010 | B2 |
7824389 | Veith | Nov 2010 | B2 |
7863497 | Magee et al. | Jan 2011 | B2 |
7931632 | Betts et al. | Apr 2011 | B2 |
7959621 | Ashton et al. | Jun 2011 | B2 |
7998127 | Betts | Aug 2011 | B2 |
8069982 | Ronn et al. | Dec 2011 | B2 |
8079994 | Richlen | Dec 2011 | B2 |
8092438 | Betts et al. | Jan 2012 | B2 |
8220632 | Oi et al. | Jul 2012 | B2 |
8226625 | Turner et al. | Jul 2012 | B2 |
8273067 | Cohen | Sep 2012 | B2 |
8388594 | Turner et al. | Mar 2013 | B2 |
8435222 | Ronn et al. | May 2013 | B2 |
8480642 | Betts | Jul 2013 | B2 |
8518004 | Betts et al. | Aug 2013 | B2 |
8568566 | Jackels et al. | Oct 2013 | B2 |
8834436 | Ronn et al. | Sep 2014 | B2 |
9028462 | Poole et al. | May 2015 | B2 |
9039669 | LaVon et al. | May 2015 | B1 |
9216118 | Roe et al. | Dec 2015 | B2 |
9254228 | Ashton | Feb 2016 | B2 |
9474657 | Berrizbeitia et al. | Oct 2016 | B2 |
9622922 | Nelson | Apr 2017 | B2 |
9649232 | Hippe et al. | May 2017 | B2 |
9907709 | Seitz et al. | Mar 2018 | B2 |
10568782 | Morimoto et al. | Feb 2020 | B2 |
10583054 | Seitz et al. | Mar 2020 | B2 |
10973709 | Seitz et al. | Apr 2021 | B2 |
20010021833 | Schmidt et al. | Sep 2001 | A1 |
20010055609 | Shantz et al. | Dec 2001 | A1 |
20020002358 | Durrance et al. | Jan 2002 | A1 |
20020004527 | Auestad et al. | Jan 2002 | A1 |
20020052588 | Otsubu | May 2002 | A1 |
20020064323 | Chin | May 2002 | A1 |
20020072023 | Shook | Jun 2002 | A1 |
20020072723 | Ronn et al. | Jun 2002 | A1 |
20020138056 | Kuen et al. | Sep 2002 | A1 |
20020148742 | Bisbal et al. | Oct 2002 | A1 |
20020151858 | Karami et al. | Oct 2002 | A1 |
20020164910 | Murray | Nov 2002 | A1 |
20020173767 | Popp et al. | Nov 2002 | A1 |
20020177829 | Fell et al. | Nov 2002 | A1 |
20020183712 | Datta et al. | Dec 2002 | A1 |
20030019508 | Tomarchio et al. | Jan 2003 | A1 |
20030073966 | Sosalla | Apr 2003 | A1 |
20030084984 | Glaug et al. | May 2003 | A1 |
20030097109 | Bruce | May 2003 | A1 |
20030114808 | Underhill et al. | Jun 2003 | A1 |
20030120231 | Wang et al. | Jun 2003 | A1 |
20030135184 | Van Gompel et al. | Jul 2003 | A1 |
20030135186 | Olson et al. | Jul 2003 | A1 |
20030136704 | Burgess | Jul 2003 | A1 |
20030139713 | Olson et al. | Jul 2003 | A1 |
20030153889 | Gibbs | Aug 2003 | A1 |
20030158532 | Magee et al. | Aug 2003 | A1 |
20030181883 | Olson et al. | Sep 2003 | A1 |
20030226266 | Ellis | Dec 2003 | A1 |
20030229327 | Imsangjan et al. | Dec 2003 | A1 |
20040006323 | Hall et al. | Jan 2004 | A1 |
20040010240 | Ronn et al. | Jan 2004 | A1 |
20040030308 | Ronn et al. | Feb 2004 | A1 |
20040030317 | Torigoshi et al. | Feb 2004 | A1 |
20040243093 | Berenson et al. | Feb 2004 | A1 |
20040052834 | West et al. | Mar 2004 | A1 |
20040064126 | Fletcher | Apr 2004 | A1 |
20040087928 | Ducker | May 2004 | A1 |
20040092904 | De, Jr. et al. | May 2004 | A1 |
20040097895 | Busam | May 2004 | A1 |
20040097897 | Ronn et al. | Jul 2004 | A1 |
20040127865 | Mitsui et al. | Jul 2004 | A1 |
20040133180 | Mori et al. | Jul 2004 | A1 |
20040162536 | Becker et al. | Aug 2004 | A1 |
20040219854 | Groitzsch et al. | Nov 2004 | A1 |
20040243083 | Matsuda et al. | Dec 2004 | A1 |
20040249354 | Matsuda et al. | Dec 2004 | A1 |
20050059943 | Suzuki et al. | Mar 2005 | A1 |
20050065492 | Cole et al. | Mar 2005 | A1 |
20050074483 | Lange | Apr 2005 | A1 |
20050085782 | Popp et al. | Apr 2005 | A1 |
20050102735 | Popp et al. | May 2005 | A1 |
20050121347 | Hanson | Jun 2005 | A1 |
20050133387 | Cohen et al. | Jun 2005 | A1 |
20050142336 | Romano, III et al. | Jun 2005 | A1 |
20050148983 | Doverbo et al. | Jul 2005 | A1 |
20050210566 | Mortell et al. | Sep 2005 | A1 |
20050256493 | Datta et al. | Nov 2005 | A1 |
20050256758 | Sierra et al. | Nov 2005 | A1 |
20050267431 | Sasaki et al. | Dec 2005 | A1 |
20060052763 | Tachibana | Mar 2006 | A1 |
20060069372 | Chakravarty | Mar 2006 | A1 |
20060082133 | Naoe et al. | Apr 2006 | A1 |
20060116656 | Hendren et al. | Jun 2006 | A1 |
20060173695 | Brandt | Aug 2006 | A1 |
20060183086 | Brandt | Aug 2006 | A1 |
20060186132 | Panning et al. | Aug 2006 | A1 |
20060193898 | Norman | Aug 2006 | A1 |
20060195357 | Klofta et al. | Aug 2006 | A1 |
20060229581 | Ulas et al. | Oct 2006 | A1 |
20060240969 | Teyssedre | Oct 2006 | A1 |
20060241558 | Ramshak | Oct 2006 | A1 |
20070016158 | Endres | Jan 2007 | A1 |
20070032766 | Liu | Feb 2007 | A1 |
20070032768 | Cohen et al. | Feb 2007 | A1 |
20070043331 | Haruki et al. | Feb 2007 | A1 |
20070141311 | Mleziva et al. | Jun 2007 | A1 |
20070142798 | Goodlander et al. | Jun 2007 | A1 |
20070151182 | Ronn et al. | Jul 2007 | A1 |
20070235263 | Legault et al. | Oct 2007 | A1 |
20070255248 | Hendren et al. | Nov 2007 | A1 |
20070287975 | Fujimoto et al. | Dec 2007 | A1 |
20070287983 | Lodge et al. | Dec 2007 | A1 |
20070293833 | Wennerback | Dec 2007 | A1 |
20080051747 | Cohen | Feb 2008 | A1 |
20080082070 | Fell et al. | Apr 2008 | A1 |
20080110782 | Burgdorf et al. | May 2008 | A1 |
20080128308 | Betts | Jun 2008 | A1 |
20080195070 | Ponomarenk et al. | Aug 2008 | A1 |
20080208155 | LaVon et al. | Aug 2008 | A1 |
20080234643 | Kaneda | Sep 2008 | A1 |
20080269038 | Schneider et al. | Oct 2008 | A1 |
20080294137 | Jansson | Nov 2008 | A1 |
20080312624 | Hundorf et al. | Dec 2008 | A1 |
20090030389 | Ashton et al. | Jan 2009 | A1 |
20090088718 | Toyoshima et al. | Apr 2009 | A1 |
20090182298 | Kumasaka | Jul 2009 | A1 |
20090240221 | Rothenberger et al. | Sep 2009 | A1 |
20090266733 | Betts et al. | Oct 2009 | A1 |
20090326504 | Kaneda | Dec 2009 | A1 |
20100022151 | Malowaniec | Jan 2010 | A1 |
20100057029 | Popp et al. | Mar 2010 | A1 |
20100106123 | Fukae | Apr 2010 | A1 |
20100108554 | Melius et al. | May 2010 | A1 |
20100130956 | Wennerback | May 2010 | A1 |
20100179495 | Roe | Jul 2010 | A1 |
20100181223 | Warren et al. | Jul 2010 | A1 |
20100193110 | Eckstein et al. | Aug 2010 | A1 |
20100280481 | Kline | Nov 2010 | A1 |
20100292666 | Olson et al. | Nov 2010 | A1 |
20110077609 | Kuwano | Mar 2011 | A1 |
20110088828 | Misek et al. | Apr 2011 | A1 |
20110098668 | Thorson et al. | Apr 2011 | A1 |
20110144602 | Long | Jun 2011 | A1 |
20110160687 | Welch et al. | Jun 2011 | A1 |
20110178490 | Lavon et al. | Jul 2011 | A1 |
20110288517 | Mori | Nov 2011 | A1 |
20120083758 | Ronn et al. | Apr 2012 | A1 |
20120157959 | Kline et al. | Jun 2012 | A1 |
20120215191 | Takino | Aug 2012 | A1 |
20120271267 | Love et al. | Oct 2012 | A1 |
20120296293 | Clifford | Nov 2012 | A1 |
20130018351 | Desai | Jan 2013 | A1 |
20130041340 | Kawakami et al. | Feb 2013 | A1 |
20130072887 | LaVon et al. | Mar 2013 | A1 |
20130138072 | Morimoto et al. | May 2013 | A1 |
20130165895 | Wennerback | Jun 2013 | A1 |
20130211355 | Nishikawa et al. | Aug 2013 | A1 |
20130211356 | Nishikawa et al. | Aug 2013 | A1 |
20130211357 | Nishikawa et al. | Aug 2013 | A1 |
20130211363 | LaVon et al. | Aug 2013 | A1 |
20130226127 | Takahashi | Aug 2013 | A1 |
20130233749 | Ronn et al. | Sep 2013 | A1 |
20130281954 | Ishihara et al. | Oct 2013 | A1 |
20130289512 | Rhodes et al. | Oct 2013 | A1 |
20130306226 | Zink et al. | Nov 2013 | A1 |
20130310795 | Glahn et al. | Nov 2013 | A1 |
20140005628 | Lavon et al. | Jan 2014 | A1 |
20140013490 | Evenson et al. | Jan 2014 | A1 |
20140018759 | Jayasinghe et al. | Jan 2014 | A1 |
20140163506 | Roe et al. | Jun 2014 | A1 |
20140171892 | Ichikawa et al. | Jun 2014 | A1 |
20140224695 | Ronn et al. | Aug 2014 | A1 |
20140288519 | Schmitz et al. | Sep 2014 | A1 |
20140288523 | Hasse et al. | Sep 2014 | A1 |
20140350508 | Popp et al. | Nov 2014 | A1 |
20140371701 | Bianichi | Dec 2014 | A1 |
20140378932 | Seitz et al. | Dec 2014 | A1 |
20150065982 | Hamilton | Mar 2015 | A1 |
20150320621 | Seitz | Jul 2015 | A1 |
20150272787 | Seitz | Oct 2015 | A1 |
20150283004 | Seitz | Oct 2015 | A1 |
20150320611 | Seitz | Nov 2015 | A1 |
20150320612 | Seitz et al. | Nov 2015 | A1 |
20150320613 | Seitz et al. | Nov 2015 | A1 |
20150320614 | Seitz | Nov 2015 | A1 |
20150320619 | Seitz et al. | Nov 2015 | A1 |
20150320620 | Seitz | Nov 2015 | A1 |
20150320622 | Seitz | Nov 2015 | A1 |
20150328056 | Een et al. | Nov 2015 | A1 |
20160058627 | Barnes et al. | Mar 2016 | A1 |
20160095764 | Seitz | Apr 2016 | A1 |
20160100989 | Seitz | Apr 2016 | A1 |
20160100995 | Seitz | Apr 2016 | A1 |
20160100996 | Seitz | Apr 2016 | A1 |
20160100997 | Seitz | Apr 2016 | A1 |
20160100999 | Seitz | Apr 2016 | A1 |
20160136004 | LaVon et al. | May 2016 | A1 |
20170049637 | Mori et al. | Feb 2017 | A1 |
20170128285 | Seitz | May 2017 | A1 |
20180147097 | Seitz et al. | May 2018 | A1 |
20180311083 | Seitz et al. | Nov 2018 | A1 |
20190000682 | Lavon et al. | Jan 2019 | A1 |
20190000683 | Lavon et al. | Jan 2019 | A1 |
20190000684 | Lavon et al. | Jan 2019 | A1 |
20190000685 | Lavon et al. | Jan 2019 | A1 |
20190029894 | Lavon et al. | Jan 2019 | A1 |
20190374401 | Seitz et al. | Dec 2019 | A1 |
20200030156 | Seitz et al. | Jan 2020 | A1 |
20200054500 | Seitz et al. | Feb 2020 | A1 |
20200229994 | Seitz et al. | Jul 2020 | A1 |
20210059865 | Seitz et al. | Mar 2021 | A1 |
Number | Date | Country |
---|---|---|
101330892 | Dec 2008 | CN |
106038076 | Oct 2016 | CN |
106659604 | May 2017 | CN |
0067916 | Dec 1982 | EP |
0309414 | Mar 1989 | EP |
0816296 | Jan 1998 | EP |
1 174 104 | Jan 2002 | EP |
1447067 | Aug 2004 | EP |
1 695 742 | Aug 2006 | EP |
1795163 | Jun 2007 | EP |
2314261 | Apr 2011 | EP |
1 603 780 | Nov 1981 | GB |
2245149 | Jan 1992 | GB |
H01162802 | Jun 1989 | JP |
H03202056 | Sep 1991 | JP |
H11-21702 | Jan 1999 | JP |
3046066 | May 2000 | JP |
2003-285890 | Jan 2002 | JP |
2003-070838 | Mar 2003 | JP |
3386124 | Mar 2003 | JP |
2003290279 | Oct 2003 | JP |
2004-057640 | Feb 2004 | JP |
2008-253290 | Oct 2008 | JP |
2009142505 | Jul 2009 | JP |
2009240694 | Oct 2009 | JP |
2011050484 | Mar 2011 | JP |
2011115229 | Jun 2011 | JP |
2014-508628 | Apr 2014 | JP |
2017064235 | Apr 2017 | JP |
WO-1999055213 | Nov 1999 | WO |
9960967 | Dec 1999 | WO |
9960974 | Dec 1999 | WO |
WO-2000027268 | May 2000 | WO |
0187206 | Nov 2001 | WO |
0213749 | Feb 2002 | WO |
WO-2002014172 | Feb 2002 | WO |
0232361 | Apr 2002 | WO |
0232363 | Apr 2002 | WO |
02069865 | Sep 2002 | WO |
02069866 | Sep 2002 | WO |
WO 2005039511 | May 2005 | WO |
2005051263 | Jun 2005 | WO |
2005110313 | Nov 2005 | WO |
2006093439 | Sep 2006 | WO |
2006115563 | Nov 2006 | WO |
2006118214 | Nov 2006 | WO |
2007016126 | Feb 2007 | WO |
2007103097 | Sep 2007 | WO |
2008023291 | Feb 2008 | WO |
2008123348 | Oct 2008 | WO |
WO2008123348 | Oct 2008 | WO |
2008135870 | Nov 2008 | WO |
2008155702 | Dec 2008 | WO |
2009013672 | Jan 2009 | WO |
2010110250 | Sep 2010 | WO |
2012054591 | Apr 2012 | WO |
2012112279 | Aug 2012 | WO |
2012154318 | Nov 2012 | WO |
2013130665 | Sep 2013 | WO |
2013161700 | Oct 2013 | WO |
2014013242 | Jan 2014 | WO |
2014205241 | Dec 2014 | WO |
2015023561 | Feb 2015 | WO |
2015171378 | Nov 2015 | WO |
2015171382 | Nov 2015 | WO |
2016057777 | Apr 2016 | WO |
2016057857 | Apr 2016 | WO |
2016057858 | Apr 2016 | WO |
2017037958 | Mar 2017 | WO |
Entry |
---|
Depend For Women Underwear, https://web.archive.org/web/20130329071618if_/http://www.depend.com/womens-solutions/products/19558, Mar. 29, 2013. |
Advertisements: “Introducing Pampers Phases”, Sep. 1991. |
“Introducing New! Luvs Phases”, Jan. 1992. |
“Introducing! The First Specially Designed Diaper Made Just For Your Walker”, Sep. 1991. |
“Dial-A-Wheel”, Sep. 1991. |
Photographs of Huggies Baby Steps Size 4 (1993). |
Photographs of Huggies Baby Steps Size 3 (1990s). |
Photographs of Huggies Baby Steps Size 4 (1991). |
Photographs of Huggies Baby Steps Size 3 (1991). |
Photographs of Huggies Ultratrim Size 4 (1992). |
Photographs of Huggies Ultratrim Size 4 (1996). |
Photographs of Huggies Ultratrim Size 2 SM/MED (1996). |
Photographs of Huggies Ultratrim Size 1 Small (1996). |
Photographs of Huggies Newborn (1996). |
Photographs of Kleenex Newborn (1979). |
Photographs of Kleenex (1980s). |
Photographs of Pampers Custom Fit (2001). |
Photographs of Pampers Phases Walker 2 (1993). |
Photographs of Pampers Phases Infant 1 (1993). |
Photographs of Pampers Phases Medium (1994). |
Copy of Huggies Baby Steps Advertisement (copyrighted 1991). |
“Brand Architecture Basics: What Is a Sub-Brand?” https://distility.com/building-brand/brand-architecture-basics-what-is-an-overbrand/, Sep. 27, 2011. |
International Search Report and Written Opinion, PCT/US2015/024628, dated Jul. 1, 2015. |
International Search Report and Written Opinion, PCT/US2015/028156, dated Jul. 24, 2015. |
International Search Report and Written Opinion, PCT/US2015/028157, dated Aug. 26, 2015. |
International Search Report and Written Opinion, PCT/US2015/028160, dated Jul. 22, 2015. |
International Search Report and Written Opinion, PCT/US2015/028169, dated Jul. 20, 2015. |
International Search Report and Written Opinion, PCT/US2015/028170, dated Jul. 16, 2015. |
International Search Report and Written Opinion, PCT/US2015/028173, dated Jul. 20, 2015. |
International Search Report and Written Opinion, PCT/US2015/053704, dated Jan. 9, 2016. |
International Search Report and Written Opinion, PCT/US2015/054664, dated Jan. 20, 2016. |
International Search Report and Written Opinion, PCT/US2015/054812, dated Jan. 21, 2016. |
International Search Report and Written Opinion, PCT/US2015/054813, dated Jan. 5, 2016. |
International Search Report and Written Opinion, PCT/US2015/054590, dated Dec. 21, 2015. |
International Search Report and Written Opinion, PCT/US2014/043199, dated Jun. 27, 2014. |
International Search Report and Written Opinion, PCT/US2014/043221, dated Sep. 12, 2014. |
U.S. Appl. No. 17/190,468, filed Mar. 3, 2021, to Bret Darren Seitz et. al. |
“Amazon.com: Depend for Women Underwear,[Small/Medium], Moderate Absorbency, 20-Count Packages (Packof 4): Health & Personal Care”, XP055615440, https://www.amazon.com/Depend-Underwear-ModerateAbsorbency-20-Count/dp/B001QCWT96?th=1, dated Jan. 1, 2011. |
“Relaxed.” Merriam-Webster.com Dictionary, Merriam-Webster, https://www.merriam-webster.com/dictionary/relaxed. Accessed dated Jun. 22, 2020. |
Amazon.com: Depend Underwear for Women, ModerateAbsorbency, Large, 19: Health & Personal Care, XP055615424, https://www.amazon.com/DependUnderwearWomenModerateAbsorbency/dp/B004Y2RWF6, dated Oct. 21, 2014. |
Assurance Underwear, “Women's Size L, 54 Count—Walmart.com”,Walmart Personal Care/Incontinence/All Incontinence, :https://www.walmart.com/ip/Assurance-Underwear-Women-s-SizeL-54-Count/28826871, XP055618665, dated Nov. 3, 2013, 5 pages. |
ASTM Committee on textiles, https://compass.astm.org/download/05585-WITHDRAWN.24337.pdf;ASTM international edition 1, dated Aug. 2011, pp. 1-7. |
EP3139885B1—Opposition Brief from Paul Hartmann—Translation, Sep. 7, 2021, 1-34, 1. |
EP3139886B1—Opposition Brief from Paul Hartmann—Translation, Sep. 9, 2021, 1-31, 1. |
EP3139885B1—Opposition Brief from Paul Hartmann, Sep. 7, 2021, 1-34, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A4.4, 1-2, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A5, 1-4, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A6, 1-2, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A7, 1-5, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A4.4, 1-2, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A5, 1-4, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A6, 1-2, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A7, 1-5, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A11, 1, 1. |
EP3139885B1—Notice of Opposition from Bardehle, Oct. 19, 2021, 1-23, 1. |
EP3139885B1—Notice of Opposition from Essity, Oct. 21, 2021, 1-34, 1. |
EP3139886B1—Notice of Opposition from Bardehle, Oct. 22, 2021, 1-22, 1. |
EP3139886B1—Notice of Opposition from Essity, Oct. 21, 2021, 1-32, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A3.1-A3.6, Oct. 10, 2012, 1-37, 1. |
EP3139886B1—Hartmann Opposition Brief Annex-A3.1-A3.6, Oct. 10, 2012, 1-37, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A11, 1, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A1.1-A1.11, Jan. 22, 2013, 1-33, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A2.1, Aug. 9, 2012, 1-100, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A2.2-A2.5, Oct. 30, 2021, 1-20, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A4.1, Jul. 2009, 1-2, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A4.2, 1-2, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A4.3, 1-16, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A8.1-A8.5, Aug. 12, 2021, 1-68, 1. |
EP3139886B1—Hartmann Opposition Brief Annex-A2.1, Aug. 29, 2021, 1-100, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A2.2-A2.5, Oct. 30, 2021, 1-20, 1. |
EP3139886B1—Hartmann Opposition Brief Annex-A4.1, Jul. 2009, 1-2, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A4.2, 1-2, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A4.3, 1-16, 1. |
EP3139886B1—Hartmann Opposition Brief Annex-A8.1-A8.5, Aug. 12, 2021, 1-68, 1. |
EP3139885B1—Declaration of Karl Karlsson, Declaration, Sep. 30, 2021, 1-5, 1. |
EP3139886B1—Declaration of Karl Karlsson, Oct. 11, 2021, 1-5, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A10, 1, 1. |
EP3139885B1—Hartmann Opposition Brief Annex A9, 1, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A9, 1, 1. |
EP3139886B1—Hartmann Opposition Brief Annex—A10, 1, 1. |
EP3139886B1 Hartmann Opposition Brief Annexes A1.1-A1.11, 1-31, 1. |
EP3139886B1—Opposition Brief from Paul Hartmann, Sep. 9, 2021, 1-31, 1. |
13342 Extended EP Search Report and Written Opinion for 21152611.6 dated Jun. 4, 2021, 7 pages. |
Third Party Opposition filed for European Patent Application Ser. No. 15722383.5, Dated Feb. 17, 2022; 06 pages. |
Third Party Opposition filed for European Patent Application Ser. No. 15722383.5, Dated Feb. 25, 2022; 05 pages. |
EP 3370674 B1—Declaration from Mr. Karl Karlsson, Declaration, Dec. 15, 2021, pp. 1-5. |
Number | Date | Country | |
---|---|---|---|
20180344536 A1 | Dec 2018 | US |
Number | Date | Country | |
---|---|---|---|
61990358 | May 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14805673 | Jul 2015 | US |
Child | 16059313 | US | |
Parent | 14699123 | Apr 2015 | US |
Child | 14805673 | US |